Introduction
Retroviral vectors persist in the host and are therefore best suited for long-term gene transfer and genereplacement therapies. So far, more than 28% of all clinical trials have utilized retroviral vectors (2004, www.wiley.co.uk/genetherapy). Nevertheless, retroviral vectors based on murine leukaemia viruses (MLV) severely limit the range of their applications because (1) they are not efficient in transducing nondividing cells and (2) their parental viruses are aetiologically linked to approximately 5-10% of all malignancies worldwide. 1 Although it was generally thought that insertional mutagenesis only occurred while replication-competent retroviruses presented, 2 it has recently become evident that the MLV-based viral vectors can likewise induce oncogene (LMO2) expression and lead to the induction of leukaemia in humans. 3 A report on the induction of leukaemia in a retroviral-transduced mouse model extends the concern on the safety of these vectors. 4 As an alternative vector system, lentiviral vectors based on HIV-1 has been under significant development. The corrections in primate models of Parkinson's disease 5 and the high efficiency of stem cell gene transfer by HIV-1-based lentiviral vectors, 6 and the first clinical trial using lentiviral vectors demonstrate a promising future for their clinical applications. There have been no direct reports on insertional mutagenesis by lentiviral vectors; however, the severe pathogenic nature of their parental virus (HIV-1) is still a major safety concern surrounding these vectors and prevents the progress with their clinical application.
A number of dysregulations of cellular gene expression can be induced by retroviral components. Viral proteins, for example, Env, Tat and Rev 7 and the LTR of HIV-1, can enhance dysregulation of host gene expression and thus neoplastic transformation. Tumorigenicity has been linked to the gag region of MMTV. 8 Modification of lentiviral vectors to eliminate pathogenic genes involved in viral replication, for example, the env, vif, vpr, tat and nef, has significantly enhanced the biosafety of lentiviral vectors. The use of multiple plasmids to provide the helper functions to reduce homology and use of a self-inactivating LTR design substantially decrease the likelihood of adverse recombination and read-through transcripts, but this also makes it extremely difficult to predict host-dependent genetic responses and tolerance to the vector modification and subsequent transduction. There are no direct reports on the combined effects of viral components in pseudotyped vectors, for example, Gag/Pol and VSV-G, on target cells. Therefore, the objective of this work is to examine the host gene profile after vector transduction in order to understand the underlying molecular events in host cells of viral components presented to target cells.
Two major sets of experiments were conducted. Initially, we used VSV-G/GFP vectors and cDNA microarray to identify differentially expressed genes by lentivector transduction. In the second approach, we employed molecular techniques to validate the potential safety significance of the targets identified by cDNA microarray and to investigate systematically the effects of individual viral components on cellular gene expression. A total of five different viral vectors, that is, HIV-1-based VSV-G/Empty (producing empty particles without any vector/transgene sequence), VSV-G/GFP, VSV-G/puro, Amph/GFP (with an MLV envelope) and MLV-based Amph/Laz, were included in this study for this purpose.
Our results revealed modest gene changes in HIV-1 vector-transduced human primary umbilical cord endothelial cells (HUVECs). We focused our interest in the potential oncogenic genes, for example, EEF-1a, eIF4g, Ku antigen, Clusterin and CD151. Overexpression of these genes was confirmed using semiquantitative RT-PCR, while elevated expression of eIF4g and Clusterin were also evident at the protein level. Clusterin encodes a sulphated glycoprotein and is also activated during carcinogenesis or during progression of prostate cancer in humans. 9 Overexpression of CD151, an adhesion molecule, has been reported to result in the induction of inflammation, angiogenesis or tumorigenesis. Such effects of lentiviral vectors on cellular gene expression should be considered in the context of future quality control and application of these vectors.
Results

Transduction of HUVECs
We wished to use HUVECs, as a model for a potential gene target for vascular diseases and solid tumours, to establish the transcriptional responses of the cells to HIV-1 vector transduction. To ensure changes of host gene expression were truly representative of vector transduction, the percentage of transduced HUVEC cells was determined before performing microarray experiments. Transduction efficiency on HUVECs was determined by measuring the percentage of cells expressing GFP and mean fluorescence intensity (MFI) of GFP using flow cytometry. In a single infection step, up to 40% of HUVECs were infected when HIV-1-based lentiviral vectors were used at an MOI of 1. Increase of the MOI from 1 to 5, 10 and 40 did not result in significant increase of the percentage of transduced cells but led to cellular toxicity (data not shown). In order to identify information in representative and particularly rare genes regulated by vector transduction, it was decided to use a high population of transduced cell population before RNA extraction. To achieve the increased transduction, we repeatedly infected HUVEC cells. The percentage of cells transduced was increased progressively over the course of consecutive transductions and more than 90% of cells were infected after four repeated infections at an interval of 48 h, even when the vectors were used at an MOI of 1 ( Figure 1a ). There was no significant difference among the vector MOI used in the systematic transduction and these findings were consistent among all independent experiments performed ( Figure 1a) . Increases of MFI of GFP proteins to a maximal two-fold were observed when cells were infected at an MOI of 40, but such increases were not directly correlated to the 10 we used early passages (less than six passages) of HUVECs and optimized culture medium and conditions (TCS) for this study. Moreover, to make sure the changes of host gene expression were the result of vector transduction rather than natural cell transformation, we assayed HUVEC cells for the expression of an endothelial cell surface marker CD31 before and after transduction and array experiments. We did not observe significant difference on CD31 expression among nontransduced, mock-and vector-transduced cells (data not shown). There was no detectable loss of CD31 expression irrespective of whether the cells were subjected to single or multiple vector transduction and the passage number performed, indicating that the increased susceptibility to vector transduction over consecutive infections and any potential gene changes were not due to the vector-independent spontaneous transformation of HUVECs.
Microarray analysis of gene expression
Microarray experiments were carried out on pooled (more than 20 donors) populations of either HIV-1-based VSV-G/GFP vector-or mock-transduced HUVEC cells. Mock transduction was conducted in parallel using conditioned medium from plasmid DNA (pEGFP-C1)-transfected cells and under conditions as close as possible to VSV-G/GFP vector treatments. Cells that were more than 90% GFP positive were used for the microarray experiments. In brief, following transduction, we used radiolabelled cDNAs from transduced HUVECs to probe a plastic human 8 K microarray, containing 8000 human cDNAs (Clontech) and AtlasImage2.1 (Clontech) to obtain and analyse raw data from arrays. Signals with discordant or absent results on the arrays were confirmed manually and discarded entirely before being subjected to statistical analysis. The signal intensity level of each gene was normalized using a global normalization method and averaged from duplicate spots on each array. Signals increased or decreased by over twofold relative to mock-transduced cell controls were considered differentially expressed. Reproducibility of the data was obtained by using triplicate preparations of labelled cDNA from three independent transduction experiments. The significance of differential expression for individual genes was calculated based on triplicate experiments using Atlas Navigator 2.0 software (Clontech).
In order to establish general patterns of difference between mock-and vector-transduced cells, we used a scatter plot of relative gene expression to mock control gene expression to display the distribution of all expressed genes after vector transduction ( Figure 2 ). Figure 2a shows the distribution of all genes detected from triplicate experiments according to gene expression ratio to the mock-treated cells on the Y-axis and gene signal intensity on the X-axis. Differential expressed genes were scattered outside of the solid lines that represent two-fold changes, among which the further away a gene (spot) from the solid line, the greater the change compared to mock transduction. These analyses revealed that out of the total 8000 human genes examined, 2% (173) genes were upregulated (Figure 2a , above the top line) while 6% (533) of genes were downregulated (Figure 2a , under the bottom line) by vector transduction. For the majority of the differential genes, changes of expression levels were between twoand three-fold, only a small number of genes were changed more than five-fold. The significance (reproducibility) of a gene in triplicate experiments were further analysed according to manufacturer's software (Clontech) and displayed red for significantly upregulated, green for downregulated and grey for insignificantly regulated genes (Figure 2b ). Although a total of 8% differential genes were identified from individual experiments (Figure 2a ), we observed a much-reduced number of genes that were significantly reproducible within triplicate experiments. The calculation of the statistical significance of a given gene was based on the change in gene expression relative the standard deviation of repeated measurements for that gene. 11 The genes confirmed as significantly modulated in all triplicate experiments were mainly located within a limited range of signal intensity (10-500, Figure 2b , X-axis), indicating that signals that were underexposed (o10) or overexposed (41000) gave less confidence and reproducibility in their measurement. The significantly regulated genes and their relative expression levels to the mock infection are summarized in Figure 3 .
Of the 28 genes significantly regulated by VSV-G/GFP transduction (Figure 3) , the represented functional categories includes transcription and translation factors (eg EEF-1a, eIF4g and Ku antigen), tumour antigens (eg CD151), complement factors (Clusterin, Lectin and Ficolin), metabolic enzymes (LDH) and signal transduction factors (RAS). As we wanted to investigate the safety of HIV-1 vectors, the elevated expression of observed genes that might have potential safety implication were further verified using semiquantitative RT-PCR.
RT-PCR analysis of some upregulated genes
Elevated expression of five genes, that is, eEF1a, eIF4g, Clusterin, Ku antigen and CD151, were further investigated by RT-PCR in three independent experiments. Serial dilutions of RNA samples (ie 2, 1, 0.1, 0.01 mg for each reaction) from mock-and vector-transduced cells were reverse transcribed, and the resultant cDNAs were used for PCR amplification. The house-keeping gene GapDH was used as an internal control. Parallel PCR reactions were set up for all tested genes and GapDH from the same reverse-transcribed RNA samples. We used optimized amounts of PCR primers (10 pM) to limit the amplification of GapDH signals from all dilutions of RNA at the same concentration of primers also used to detect changes in all tested samples. Equal amounts of GapDH signal were detected from both vector-and mock-transduced cells (Figure 4a ), demonstrating a reliable internal control of reactions. The PCR values of tested genes were normalized to GapDH to further account for possible differences in the reaction preparation. The PCR results are shown in Figure 4a and the relative gene expression levels compared to Figure 4b in parallel with the results from microarray. Although there were differences in the fold changes detected using the microarray and RT-PCR methods (Figure 4b ), RT-PCR results correlated well with microarray data and confirmed the general trends seen for the five genes tested. Although the expression ratios calculated by RT-PCR were generally higher than those obtained by microarray, this difference may be related to spot saturation of microarray experiments or amplification methods used for PCR.
Western blot analysis on cellular protein expression
As observed in microarray and PCR results, VSV-G/ GFP-transduced HUVECs showed markedly increased levels of Clusterin, CD151 and eEF1a (over five-fold) and a modest increase in eIF4g and Ku antigen expression (by a factor of 2.1, Figure 4b) ; we therefore wished to investigate the expression changes at the protein level. For this, we performed Western blot using commercially available antibodies for Clusterin and eIF4g. Equal amounts of total cellular proteins (20 mg) from mockand vector-transduced HUVECs was separated using Figure 6 ), can significantly induce the expression of Clusterin in HUVEC cells. We can also verify the induction effects of HIV-1 proteins (Gag/Pol) on Clusterin expression using an MLV-based vector, as shown in Figure 6 (lane 4). This finding was further confirmed at transcriptional level by RT-PCR using the physical particles (carrying only VSV-G and Gag/Pol proteins, Figure 7 ).
Discussion
Although HIV-1-based lentiviral vectors have been well characterized for their potential applications for gene therapy involving a number of cell and tissue types, for example, neurones, bone marrow, stem cells, lymphocytes and vascular endothelium, little is known on the cellular responses of target cells to vector transduction. We reason that by investigating the host response we shall be able to assess at least the potential effects of the vectors on targeted cells and on the interaction between vectors and the host. Such study would be beneficial for the understanding of the molecular mechanism of vector transduction and influence future modification and assessment of gene therapy vectors. To achieve this, we used microarray technology to examine the global response of HUVECs, a potential target for vascular diseases and cancer, to HIV-1-based VSV-G/GFP vector transduction. We have initially identified 8% of a total of 8000 human genes examined for which expression level was two-fold greater/less compared with mock infection from such microarray experiments. However, only 28 genes were reproducibly detected in triplicate experiments and their relative expression levels to mock transduction were experimentally significant in terms of the standard errors of triplicate measurements. This indicates that although microarray can identify expression changes in thousands of genes in any one experiment, it is important to determine the significance of these changes using multiple experiments before drawing conclusion regarding the significance of the data. In particular, genes with very low or very high expression need to be interpreted cautiously, as these seem particularly associated with irreproducible results. Detection of induced changes in gene expression using our adopted approach is also limited to include transient and even short-term effects. Some of these may be associated with safety in patients but others may be insufficiently sustained to mediate significant effects. Relatively few genes in HUVECs were significantly affected by a HIV-1-based vector (VSV-G/GFP), reflecting a modest effect of lentiviral vectors on such cells. This finding is consistent with results obtained from HIV-1 vector-infected human B-cell lines, 12 although the number of genes reported in our study was even smaller. This may due to the fact that (1) we only screened 8000 human cDNA rather than 12 000 as in the B-cell line study, (2) our data were from and only considered significant if found using triplicate data sets instead of duplicates used by Mitchell et al 12 and (3) the origin and characteristics of the cells used are different. Using RT-PCR, we confirmed the expression changes of all five genes examined and demonstrated correlation of the results obtained with microarray data. We were also able to confirm the transcriptional changes of eIF4g and Clusterin at the protein level. The consistency of results confirmed using PCR and Western blots gave us confidence in our microarray data. Interestingly, of the 28 significantly modulated genes we identified in HUVEC cells, six genes (21%), that is, eIF3, GJB1, SNRPB, hNRPA/B, FK506 and proteasome were also reported in HIV-1 vector-transduced B-cell lines. 12 These The potential function of differentially expressed genes includes the regulation of transcription and translation, RNA processing, DNA metabolism and immune responses. Some of the genes have been demonstrated as playing a role in signalling and DNA repair after viral infection. In particular, our results suggest for the first time that lentiviral vector transduction regulates expression of some genes, for example, CD151, Ku antigen and Clusterin, with a reported oncogenic potential, [13] [14] [15] which may require further consideration and investigation when considering the clinical application of these vectors. For example, Clusterin, a heterodimeric highly conserved glycoprotein, has chaperone-like activity and shares functional similarities with heat-shock proteins. 16 A high mannose form of Clusterin (B60 kDa) is located in the cytoplasm of several cancer and normal proliferating cells. 17 Intriguingly, increased expression of Clusterin has been observed in several cases of in vivo cancer progression and tumour formation. 18, 19 Interestingly, it has been reported that the intracellular form of Clusterin interacts with DNA helicase Ku antigen, which is also upregulated in our study. Association between Clusterin and Ku antigen is stress inducible and has been correlated with the pathophysiology of many Clusterin-related diseases including carcinogenesis. 20 CD151 also has potential oncogenic properties. Upregulation of CD151 has been shown to be associated with the metastatic potential of a human epidermoid tumour line in an in vivo model 14 and the induction of inflammation, angiogenesis, tumorigenesis and adult T-cell leukaemia. [13] [14] [15] 21 The upregulation of cellular genes, such as CD151, Clusterin and Ku antigen, may result from the aberrant regulation of translational factors, for example, eIF4g and EEF-1a, as detected in the microarray experiments. It has been reported that these factors showed potential involvement in tumorigenesis. Increased protein synthesis is necessary for the transition of cells from quiescence to proliferation and it has been suggested that constitutive activation of translational machinery might be one common mechanism by which various oncogenes exert their transforming function. 22 For example, expression of the translation initiation factor, eIF4E, a counterpart of eIF4g, is increased in oncogenetransformed cells. [22] [23] [24] [25] It has been suggested that interaction of eIF4g with HIV Gag proteins (MA) and subsequent cleavage of eIF4g by HIV-1 proteases may lead to a virus-induced inhibition of cellular mRNA translation. [26] [27] [28] [29] [30] Substantial modification to generate the HIV-1-based vectors may alter the intrinsic interaction of viral proteins and lead to the aberrant regulation of cellular gene expression. The significance and implication of cellular gene regulation in the safety of HIV-1-based vectors should be investigated further. Particularly, the effects of significant amounts of viral proteins, for example, Gag/Pol, and VSV-G, presented to target cells are still unknown. Moreover, pseudotyped envelope proteins, for example, VSV-G, provide lentiviral vectors with an extended tropism, yet little is known concerning the potential effect of such modifications on non-natural host cells. After systematically comparing the effects of five different vectors on Clusterin expression, we observed that the elevated expression of Clusterin is due to the presence of HIV-1 Gag/Pol proteins.
There have been few reports on the regulatory functions of HIV-1 Gag on gene expression in infected cells. Purified HIV-1 Gag/p17 matrix protein significantly increased production of proinflammatory cytokines, for example, TNF-a and IFN-g, and thus has all the characteristics of a HIV-1 virus capable of influencing activation and proliferation of HIV-1 target cells. 31 It has been reported that the gag region of HIV-1 contains an intragenic regulatory element that functions as an enhancer on the heterologous TK promoter from herpes simplex virus. 32 Direct involvement of Gag proteins in tumour induction has been evident in mouse mammary tumour viruses. 8 Also, HIV-1 has two proteins with zincfinger-like structures located at Tat and nucleocapsid protein NCp7 in the gag region 33 that function synergistically to enhance LTR activities in infected cells. 34 It is evident that Tat activates the transcription of several cellular genes, for example, cytokines, and induces the proliferation of mononuclear and sarcoma cells. 7, 34 In comparison with Tat, NCp7 contains two classic zincfinger DNA-binding motifs, which are found in authentic transcription factors. NCp7 may bind to LTRs and cooperatively enhance activities of transcription factors, for example, NF-kB, SP1 and TFIIB. 35 It has also been suggested that NCp7 may interrupt cellular gene function by out-competing the surrounding cellular promoters for transcription factors and thus lead to the transcriptional regulation of cellular genes. 35 Our results demonstrate a regulatory function of HIV proteins, for example, Gag/Pol, and possibly together with recruited cellular proteins in particles, on cellular gene expression. The increased expression of Clusterin after VSV-G/Empty (physical particles) transduction emphasizes the importance of the quality of vector preparations, because contamination of physical particles is still a common problem in HIV-1-based vector production, which sometimes can be as high as 100 physical particles to one infectious particle. The induction of Clusterin as detected in our study maybe due to the large amount of Gag/Pol proteins from physical particles rather than an MOI of 5 used. Qualitative and quantitative studies on the correlation of cellular gene expression with vector components and their implication in vector safety will facilitate the quality control and the future regulation of HIV-1-based viral vectors.
Materials and methods
Vector production
Third-generation HIV-1-based lentiviral vector plasmids were kindly provided by Dr D Trono (Geneva). Five different viral vectors were used in this study, that is, HIV-1-based (1) VSV-G/GFP, (2) VSV-G/puro, (3) VSV-G/Empty (without any vector/transgene sequence), (4) Amph/GFP (with an MLV envelope) and (5) murine leukaemia virus-based Amph/Laz. Lentiviral vector particles were produced by transient transfection of human embryonic kidney 293T cells (ATCC) with a weight ratio of 3:2:1 vector:packaging:envelope plasmids using LipofectAMINE (Invitrogen) following the manufacturer's protocols. Viral supernatants were harvested 48 h post-transfection and/or concentrated by ultraSafety assessment of HIV-1-based vectors Y Zhao et al centrifugation. 36 Plasmid DNA ((pEGFP-C1) at a concentration of 10 mg DNA/5 Â 10 6 cells) were also transfected using an identical condition as vector DNA to provide a mock control in all experiments. Transduction titres of viral vectors were determined on 293T cells and calculated based on the dilution that gave 5-10% transduction by FACS (for GFP vectors) or the number of colony formation (for puro vectors). VSV-G/Empty particles were produced, concentrated and assayed in parallel with VSV-G/GFP vectors and further titered by HIV-1 p24 ELISA. MLV-based vector (Amph/Laz) was produced using a packaging cell line, TE-Fly-A13. 37 HIV-1 p24 ELISA HIV-1 p24 ELISA was performed as a supporting assay to determine the titres of VSV-G/Empty particles. Dilutions of p24 standard samples (EVA620, NIBSC) and viral vector stocks were assayed for p24 by standard ELISA protocols using sheep anti-HIV-p24 (D7320, NIBSC) for capture antibodies and biotinylated monoclonal mouse anti-p24 Gag (ADP454, NIBSC) as detection antibody. Vector titres were calculated based on standard formula (10 4 viral particles/1 pg p24 proteins) and normalized by transduction titres of VSV-G/GFP for the determination of MOI used in subsequent transduction assays.
Transduction assays on HUVECs
HUVECs (TCS Ltd and National Cancer Institute, USA) were transduced with viral vectors in the presence of Polybrene (8 mg/ml, Sigma). Conditioned medium from 293T cells transfected with plasmid DNA (pEGFP-C1, Clontech) was used as a control for mock infection. Transduction on HUVECs of VSV-G/GFP vectors was determined by the percentage of GFP-positive cells using flow cytometry. Cells transduced with VSV-G/puro vectors were subjected to selection medium containing puromycin (5 mg/ml, Sigma) for 5 days before the percentage of transduced cells were calculated.
Microarray
Primary HUVEC cells were transduced with VSV-G/ GFP or conditioned control medium from cells transfected with plasmid DNA (pEGFP-C1) at an MOI of 5 (determined according to transduction titre on 293T cells). Cells (90% GFP-positive) were harvested 48 h after four consecutive transductions. Total RNA was harvested from the transduced cells and used to generate hybridization probes. The probes were then hybridized to a cDNA microarray containing 8000 human cellular genes (Clontech). Data were generated from triplicate experiments. For data analysis, signal intensities were measured and normalized with the AtlasImage analysis software (Clontech). The expression levels of all genes on the arrays were compared against the control group (mock infection). Genes with differences of 2.0-fold or larger reflecting significant changes were further analysed.
RT-PCR
Total RNA was digested with 10 U DNAse I (Invitrogen) and was then reverse-transcribed with oligo(dT) primers and 20 U of M-MLV RT (Invitrogen) for 1 h at 451C. The resultant cDNA was used for PCR at the conditions of 30 cycles of 1 min at 961C, 1 min at 521C and 1 min at 721C. The primers used to detect desired genes were as 
Western blot
Cell lysate was prepared from mock-or vector-transduced HUVEC cells in SDS lysis buffer, quantified using BioRad total protein reagents (BioRad) and normalized at a concentration of 10 mg/ml of total proteins in SDS-PAGE loading buffer. Equal amount of total protein (20 mg) from differently transduced cells were electrophoresed and electroblotted to Hybond ECL membranes (Amersham). The following primary antibodies were used: mouse anti-HIV-1 GAG (EVA365/6, NIBSC), mouse monoclonal anti-CD31 (TCS), mouse monoclonal anti-eIF4g (mAb, BD Biosciences), mouse anti-Clusterin (Biogenesis), mouse anti-CD151 (BD Biosciences) and goat anti-EF-Tu polyclonal antibody (Santa Cruz). The blots were further assayed with goat anti-mouse or rabbit anti-goat horseradish peroxidase conjugates (Sigma). The immunoreactive proteins were detected using ECL chemiluminescence reagents (Amersham).
